White-coat hypertension and cardiovascular events: a meta-analysis

Alexandros Briasoulis1, Emmanuel Androulakis, Mohan Palla

  • 1aDivision of Cardiology, Wayne State University/Detroit Medical Center, Detroit, Michigan, USA bJohn Radcliffe Hospital, University of Oxford, Oxford cBarts Heart Centre, St Bartholomew's Hospital, London, UK dDepartment of Cardiology, Hippokration Hospital, University of Athens, Athens, Greece.

Journal of Hypertension
|January 7, 2016
PubMed

Insights

White-coat hypertension (WCH) increases cardiovascular risks compared to normal blood pressure. However, sustained hypertension poses significantly higher risks for cardiovascular events and mortality.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Epidemiology

Background:

  • White-coat hypertension (WCH) is prevalent in pediatric and geriatric populations.
  • The long-term prognostic implications of WCH remain under investigation.

Purpose of the Study:

  • To systematically review cohort studies on WCH.
  • To compare cardiovascular outcomes, stroke, and mortality in WCH versus normotension and sustained hypertension.

Main Methods:

  • Systematic search of MEDLINE, PUBMED, EMBASE, and Cochrane databases.
  • Inclusion of prospective cohort studies assessing office, ambulatory, and/or home blood pressure.
  • Analysis of 14 studies with 29,100 participants (mean age 59, follow-up 8 years).

Main Results:

  • WCH patients showed increased cardiovascular morbidity and mortality versus normotensive individuals.
  • No significant difference in all-cause mortality or stroke risk between WCH and normotensive groups.
  • Sustained hypertension significantly elevated cardiovascular disease, mortality, and stroke risks compared to WCH.

Conclusions:

  • Cardiovascular risks associated with WCH are slightly elevated compared to normotension.
  • Risks for WCH are substantially lower than those observed in sustained hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
711
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
664
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
741
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K